Citations 1
A phase II randomized, placebo-controlled trial evaluating nintedanib versus placebo as prophylaxis against radiation pneumonitis in patients with unresectable non-small cell lung cancer (NSCLC ) undergoing chemoradiation therapy (CRT): A National Comprehe
Dy, Grace K. , Kim, Eric S. , Baumgart, Megan , Patrick, C. , Molina, Julian R. , Adjei, Alex A. , Mattes, Malcolm David , Gadgeel, Shirish M. , Attwood, Kristopher M.
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: TPS8572-TPS8572
